Health Condition 1: J219- Acute bronchiolitis, unspecified
Conditions
Interventions
Intervention1: Children receiving Montelukast: We will give Montelukast (dispersible tablet) 4mg (once daily) orally to children (aged 3 months to 2 years) hospitalised with acute moderate bronchiolit
Sponsors
Megadeepan S
Eligibility
Inclusion criteria
Inclusion criteria: 1) Children aged 3 months to 2 years with first episode of wheezing having a prodromal history consistent with upper respiratory tract infection followed by wheezing and/or crackles on auscultation. 2) WANG score 4 to 8.
Exclusion criteria
Exclusion criteria: 1) Age greater than 2 years and age less than 3 months. 2) Baby born premature (less than 34 weeks). 3) Previous hospital admission due to any respiratory illness. 4) Previous bronchodilator use before the present illness. 5) Previous steroid use before the present illness. 6) Chronic cardiac or pulmonary disease. 7) History of atopy in child or family. 8) Oxygen saturation <= 85% in room air at the time of recruitment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess and compare the change in length of hospital stay between groups of children receiving Montelukast and not receiving Montelukast in children hospitalised with acute moderate bronchiolitis.Timepoint: From the time of admission to time of discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change in clinical severity score (WANG score). 2) Oxygen requirement. 3) Intravenous fluid requirement. 4) Incidence of adverse effects following Montelukast administration.Timepoint: From the time of admission to time of discharge. | — |
Countries
India
Contacts
Public ContactMegadeepan
Swami Dayanand hospital
Outcome results
None listed